- Potential Benefits of Neoadjuvant Chemotherapy in Clinically Node-Positive Luminal Subtypeâ» Breast Cancer
-
Kim HS, Yoo TK, Park WC, Chae BJ
- KMID: 2458862
- J Breast Cancer.
- 2019 Sep;22(3):412-424.
- doi: 10.4048/jbc.2019.22.e35
PURPOSE: Neoadjuvant chemotherapy (NAC) is less effective for luminal breast cancer because luminal breast cancer has a lower rate of pathological complete response (pCR) after NAC than human epidermal growth... -
- CITED
-
- Close
- SHARE
-
- Close
- Gastric Complications after Adjuvant Radiotherapy for Breast Cancer
-
Cho WK, Choi DH, Park W, Kim H, Kim S, Shin MH, Cha H
- KMID: 2458866
- J Breast Cancer.
- 2019 Sep;22(3):464-471.
- doi: 10.4048/jbc.2019.22.e42
PURPOSE: In some patients who receive adjuvant radiotherapy (RT) for the left breast, the stomach is located inside the RT field. This study investigates the incidence of gastric complications following... -
- CITED
-
- Close
- SHARE
-
- Close
- Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer
-
Nakhjavani M, Hardingham JE, Palethorpe HM, Price TJ, Townsend A
- KMID: 2458857
- J Breast Cancer.
- 2019 Sep;22(3):341-361.
- doi: 10.4048/jbc.2019.22.e39
Breast cancer (BC) is still the most common cancer among women worldwide. Amongst the subtypes of BC, triple negative breast cancer (TNBC) is characterized by deficient expression of estrogen, progesterone,... -
- CITED
-
- Close
- SHARE
-
- Close
- Primary Histiocytic Sarcoma Presenting as a Breast Mass: A Case Report
-
Bang S, Kim Y, Chung MS, Park JS, Choi YY, Shin SJ
- KMID: 2458869
- J Breast Cancer.
- 2019 Sep;22(3):491-496.
- doi: 10.4048/jbc.2019.22.e32
Histiocytic sarcoma is a rare hematologic malignancy, with very few cases of primary histiocytic sarcoma of the breast described in English scientific literature. Herein, we describe a case of primary... -
- CITED
-
- Close
- SHARE
-
- Close
- Human Epidermal Growth Factor Receptor 2-Subtype Invasive Ductal Carcinoma Recurring as Basal-Human Epidermal Growth Factor Receptor 2-Subtype Squamous Cell Carcinoma
-
An J, Yoo Y, Kim HG, Woo J, Lee KE, Kwon H, Lim W, Sung SH, Paik NS, Moon BI
- KMID: 2458868
- J Breast Cancer.
- 2019 Sep;22(3):484-490.
- doi: 10.4048/jbc.2019.22.e31
Squamous cell carcinoma of the breast and its subtype, basal-human epidermal growth factor receptor 2 (HER2) phenotype, are very rare. Herein, we report a patient who developed recurrence of squamous... -
- CITED
-
- Close
- SHARE
-
- Close
- Prediction of Late Breast Cancer-Specific Mortality in Recurrence-Free Breast Cancer Survivors Treated for Five Years with Tamoxifen
-
Baek SY, Kwon JY, Lee YJ, Gwark SC, Lee SB, Kim J, Chung IY, Ko BS, Kim HJ, Kim SB, Ahn SD, Gong G, Son BH, Ahn SH, Lee JW
- KMID: 2458860
- J Breast Cancer.
- 2019 Sep;22(3):387-398.
- doi: 10.4048/jbc.2019.22.e33
PURPOSE: The extension of endocrine therapy beyond 5 years for recurrence-free survivors of breast cancer improves survival; however, the issue on how to clinically identify appropriate candidates remains controversial. This... -
- CITED
-
- Close
- SHARE
-
- Close
- Measuring Tumor Extent Based on Subtypes Using Magnetic Resonance Imaging: Radiologic-Pathologic Discordance and High Positive Margin Rates in Breast Cancer
-
Bae SJ, Ahn SG, Yoon CI, Yang BS, Lee HW, Son EJ, Jeong J
- KMID: 2458865
- J Breast Cancer.
- 2019 Sep;22(3):453-463.
- doi: 10.4048/jbc.2019.22.e36
PURPOSE: We evaluated the clinical value of breast magnetic resonance imaging (MRI) in patients who underwent breast-conserving surgery (BCS). The degree of correlation between pathology size and MRI or ultrasonography... -
- CITED
-
- Close
- SHARE
-
- Close
- Changes in Biomarker Status in Metastatic Breast Cancer and Their Prognostic Value
-
Woo JW, Chung YR, Ahn S, Kang E, Kim EK, Kim SH, Kim JH, Kim IA, Park SY
- KMID: 2458864
- J Breast Cancer.
- 2019 Sep;22(3):439-452.
- doi: 10.4048/jbc.2019.22.e38
PURPOSE: There is cumulative evidence that changes in biomarker status occur frequently during the metastatic progression of breast cancer and affect treatment response. The purpose of this study was to... -
- CITED
-
- Close
- SHARE
-
- Close
- The Role of Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio in Predicting Neoadjuvant Chemotherapy Response in Breast Cancer
-
Kim HY, Kim TH, Yoon HK, Lee A
- KMID: 2458863
- J Breast Cancer.
- 2019 Sep;22(3):425-438.
- doi: 10.4048/jbc.2019.22.e41
PURPOSE: The role of the host immunologic environment is crucial in cancer progression. Recent studies revealed that neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR), are possible surrogate markers of outcome... -
- CITED
-
- Close
- SHARE
-
- Close
- Early Rehabilitation after Total Mastectomy and Immediate Reconstruction with Tissue Expander Insertion in Breast Cancer Patients: A Retrospective Case-control Study
-
Kim KH, Yeo SM, Cheong IY, Kim Y, Jeon BJ, Hwang JH
- KMID: 2458867
- J Breast Cancer.
- 2019 Sep;22(3):472-483.
- doi: 10.4048/jbc.2019.22.e40
PURPOSE: To prevent surgical site complications, many plastic surgeons use the so-called “conventional protocol,†which immobilizes the shoulder and upper arm for 1 month after reconstruction. In an effort to... -
- CITED
-
- Close
- SHARE
-
- Close
- Anticancer Activity of Tubulosine through Suppression of Interleukin-6-Induced Janus Kinase 2/Signal Transducer and Activation of Transcription 3 Signaling
-
Kim BH, Yi EH, Li YC, Park IC, Park JY, Ye SK
- KMID: 2458858
- J Breast Cancer.
- 2019 Sep;22(3):362-374.
- doi: 10.4048/jbc.2019.22.e34
PURPOSE: The chemical structure of tubulosine has been known since the mid-1960s. However, little is known about its biological and pharmacological functions. The aim of this study was to investigate... -
- CITED
-
- Close
- SHARE
-
- Close
- Weight Gain during Neoadjuvant Chemotherapy is Associated with Worse Outcome among the Patients with Operable Breast Cancer
-
Fang Q, Huang J, Gan L, Shen K, Chen X, Wu B
- KMID: 2458861
- J Breast Cancer.
- 2019 Sep;22(3):399-411.
- doi: 10.4048/jbc.2019.22.e37
PURPOSE: This study was aimed at identifying the influence of initial weight and weight change during neoadjuvant chemotherapy (NAC) on pathologic complete response (pCR) and long-term survival in Chinese patients... -
- CITED
-
- Close
- SHARE
-
- Close
- In Vitro and In Vivo Study on the Effect of Lysosome-associated Protein Transmembrane 4 Beta on the Progression of Breast Cancer
-
Tao D, Liang J, Pan Y, Zhou Y, Feng Y, Zhang L, Xu J, Wang H, He P, Yao J, Zhao Y, Ning Q, Wang W, Jiang W, Zheng J, Wu X
- KMID: 2458859
- J Breast Cancer.
- 2019 Sep;22(3):375-386.
- doi: 10.4048/jbc.2019.22.e43
PURPOSE: Although the effect of lysosome-associated protein transmembrane 4 beta (LAPTM4B) on the proliferation, migration, and invasion of breast cancer (BC) cells has already been studied, its specific role in... -
- CITED
-
- Close
- SHARE
-
- Close
